Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.

Twenty-two human immunodeficiency virus type 1 (HIV-1)-infected, asymptomatic volunteers with CD4 cell counts of >600 cells/mm3 who were enrolled in a phase I immunotherapy trial comparing two schedules of immunization of an HIV-1 IIIB-based recombinant gp160 (rgp160) experimental vaccine were evalu...

Descripció completa

Dades bibliogràfiques

Publicat a:	Clin Diagn Lab Immunol
Autors principals:	Lambert, J S, Viscidi, R, Walker, M C, Clayman, B, Winget, M, Wolff, M, Schwartz, D H
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 1997
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC170523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9144368/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.4.3.302-308.1997
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!